Vaccination Against COVID-19 in Cancer

NAActive, not recruitingINTERVENTIONAL

Enrollment

791

Participants

Timeline

Start Date

January 8, 2021

Primary Completion Date

June 4, 2021

Study Completion Date

April 30, 2025

Conditions

Cancer

Interventions

BIOLOGICAL

mRNA-1273 SARS-CoV-2 vaccine from Moderna

All participants will receive two vaccinations against COVID-19 according to standard of care.

Trial Locations (3)

NKI-AvL, Amsterdam

Erasmus MC, Rotterdam

UMCG, Groningen

All Listed Sponsors

lead

University Medical Center Groningen

OTHER